Jun 7, 2025, 10:38
Help Us Learn More About Hemophilia B – ATHN
American Thrombosis and Hemostasis Network (ATHN) shared a post on LinkedIn:
“Help us learn more about Hemophilia B!
New research study open studying the safety and effectiveness of Rebinyn® (Coagulation Factor IX (Recombinant) GlycoPEGylated).”
Learn how to join today!
Find more posts on Hemostasis Today.
-
Jun 7, 2026, 15:50Venkateshwarlu Bairi: AVEVA Hyderabad Supports Children Living with Thalassemia and Sickle Cell Conditions
-
Jun 7, 2026, 15:48José Antonio García Erce: Hemochromatosis and Blood Donation
-
Jun 7, 2026, 15:29Marc Scherlinger: Uncovering the Immuno-Inflammatory Functions of Platelets at EULAR 2026
-
Jun 7, 2026, 15:18Huyen Nguyen: Highlights from the NCCN Cancer-Associated Venous Thromboembolic Disease Guidelines
-
Jun 7, 2026, 14:35Erica Wood: WHO Launches Landmark Action Framework to Secure Safe and Equitable Blood Supply Worldwide
-
Jun 7, 2026, 14:27Jorge Lima: Amniotic Fluid Embolism and Its Impact on Maternal and Perinatal Outcomes
-
Jun 7, 2026, 14:20Utsab Raj Panta: Navigating the A–E Classification in Acute Pulmonary Embolism
-
Jun 7, 2026, 14:19Ming Y Lim: The Burden and Impact of Bleeding in Newly Diagnosed Cancer Patients
-
Jun 7, 2026, 14:16What Would You Like to Know About Hemophilia Gene Therapy? – ISTH